Free tool
Healthcare stocks
We cover 48 companies in the Healthcare sector. The median market value in the group is $42.01B. Across the group, the median move over the past trading day is 0.00%. 96% of the 47 with a 200-day average trade above it. Price change over the past year runs from −6.1% to +109.3% across the middle 80 percent of the group, with a median of +34.5%.
Other lists in this group
Table
48 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.15 BRL | +9.49% | −0.22% | +22.22% |
| PFIZ34.SA | Pfizer Inc. | 36.48 BRL | +12.73% | +10.34% | +11.58% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| H1CA34.SA | HCA Healthcare, Inc. | 112.22 BRL | +4.87% | −11.77% | +2.99% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 717.90 EUR | +25.00% | +8.96% | −5.91% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| A1RG34.SA | argenx SE | 209.16 BRL | +14.71% | +11.37% | +36.97% |
| CSL.AX | CSL Limited | 173.59 AUD | +35.54% | +2.25% | −16.37% |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +2.81% | +12.61% | +18.03% |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +1.73% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | 195.72 BRL | +39.80% | −113.58% | −113.87% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | 97.74 BRL | +24.04% | +17.29% | +94.70% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| QTS.DE | IQVIA Holdings Inc. | 222.10 EUR | +19.34% | +15.23% | −4.04% |
| V2EE34.SA | Veeva Systems Inc. | 43.28 BRL | +37.40% | +4.74% | −18.65% |
| WATC34.SA | Waters Corporation | 476.58 BRL | 0.00% | −9.22% | +24.76% |
| I1LM34.SA | Illumina, Inc. | 232.57 BRL | +19.43% | +55.21% | +113.13% |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| BIIB34.SA | Biogen Inc. | 188.29 BRL | +9.47% | +16.95% | +47.86% |
| B1NT34.SA | BioNTech SE | 36.04 BRL | +21.72% | +9.71% | +2.68% |
| 22UA.DE | BioNTech SE | 100.00 EUR | +23.08% | +21.29% | +14.09% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| I1NC34.SA | Incyte Corporation | 328.02 BRL | +11.19% | +18.38% | +41.91% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | 121.92 BRL | +6.75% | +6.21% | −5.04% |
| C1OO34.SA | The Cooper Companies, Inc. | 39.92 BRL | +6.97% | −13.31% | −0.89% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +4.97% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| U1HS34.SA | Universal Health Services, Inc. | 230.44 BRL | +11.86% | −26.92% | −6.44% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.